{"status":"OK","data":{"advertisement":{"id":242210,"title":"ZAPYTANIE OFERTOWE nr 16/2024/G/KONGO","partial_offer_allowed":false,"publication_date":"2024-01-31","submission_deadline":"2024-02-08 23:59:59","planned_sign_date":"2024-02-01","supplementary_orders":null,"terms_of_contract_change":null,"created_at":"2024-01-31 09:11:44","modified_at":"2024-02-09 00:00:03","contact_persons":[{"id":64,"forename":"Paulina","surname":"Gruszka","phone_number":"","email":"paulina.gruszka@celonpharma.com","created_by":null,"created_at":"2025-05-14 12:08:24","modified_at":"2025-05-14 12:08:24","modified_by":null}],"orders":[{"id":392859,"estimated_value":null,"order_items":[{"id":442985,"description":"Monomethyl Auristatin E (CAS: 474645-27-7) \n(Preferowany produkt MCE o nr kat. HY-15162 lub r\u00f3wnowa\u017cny)\n","warranty_period":null,"cpv_items":[{"id":3148,"code":"33696500-0","name":"Odczynniki laboratoryjne"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"mazowieckie","poviat":"nowodworski","commune":"Czosn\u00f3w","locality":"Kazu\u0144 Nowy","created_by":null,"created_at":"2024-01-31 09:11:44","modified_at":"2024-01-31 09:11:44","modified_by":null,"id":496400,"type":{"id":1,"name":"adres"},"group_uuid":"cd5dc627-1cb8-4245-a62f-abd47bf64438"}],"participation_conditions":[],"category":{"id":3,"name":"Dostawa"},"subcategory":{"id":15,"name":"Dostawy inne"},"created_by":null,"created_at":"2024-01-31 09:11:44","modified_at":"2024-01-31 09:11:44","modified_by":null,"group_uuid":"4358739d-f214-4036-814e-259088a6a77a"}],"evaluation_criteria":[{"id":674512,"price_criterion":true,"description":"Cena (C) \u2013 100 pkt (100%)","created_by":null,"created_at":"2024-01-31 09:11:44","modified_at":"2024-01-31 09:11:44","modified_by":null,"group_uuid":"a839eac1-e874-498d-a903-a2ca76d2fc21"}],"is_variant":false,"title":"Monomethyl Auristatin E (CAS: 474645-27-7) ","order_node":{"id":298043},"created_by":null,"created_at":"2024-01-31 09:11:44","modified_at":"2024-01-31 09:11:44","modified_by":null}],"created_by":{"id":177,"contact_persons":[]},"modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":2,"label":"PUBLISHED","name":"Opublikowane"},"advertiser_address_details":{"name":"Celon Pharma S.A.","identification_number_type":"nip","identification_number":"1181642061","address":{"country":"Polska","voivodeship":"mazowieckie","poviat":"warszawski zachodni","commune":"\u0141omianki","locality":"Kie\u0142pin","created_by":null,"created_at":null,"modified_at":null,"modified_by":null,"id":643967,"street":"Ogrodowa ","number_description":"2A","postcode":"05-092"},"created_by":{"id":177,"contact_persons":[]},"created_at":"2024-01-31 09:11:44","modified_at":"2024-01-31 09:11:44","modified_by":{"id":177,"contact_persons":[]},"id":242767},"advertisement":{"id":184306,"number":"2024-177-184306","publication_date":"2024-01-31","created_by":{"id":177,"contact_persons":[]},"created_at":"2024-01-31 09:11:44","modified_at":"2024-02-09 00:00:03","modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":6,"label":"RESOLVED","name":"Rozstrzygni\u0119te"},"all_available_version_ids":[242210],"enrollment":null,"projects":[{"id":43069,"name":"Opracowanie pierwszego w klasie innowacyjnego immunokoniugatu o dzia\u0142aniu immunomoduluj\u0105cym i cytotoksycznym, jako kandydata na lek w terapii nowotwor\u00f3w","number":"A032/23","activity":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:22:25","modified_at":"2023-02-01 09:22:25","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"region":null,"institution":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:27:55","modified_at":"2023-02-01 09:27:55","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"full_number":"FENG.01.01-IP.01-A032/23","perspective":{},"programme":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:21:41","modified_at":"2023-02-01 09:21:41","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"priority":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:21:51","modified_at":"2023-02-01 09:21:51","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"type":"project","created_by":{"id":177,"contact_persons":[]},"created_at":"2023-12-06 11:00:15","modified_at":"2023-12-06 11:00:15","modified_by":{"id":177,"contact_persons":[]}}],"is_author":false,"is_admin":false},"attachments":[{"origin":{"id":242210,"publication_date":"2024-01-31"},"id":1237045,"name":"Zapytanie ofertowe","file":{"id":1378858,"name":"ZO_16_2024_G_KONGO.pdf","created_at":"2024-01-31 09:10:13","created_by":{"forename":"Paulina","surname":"Gruszka"},"uri":"/api/files/1378858"},"group_uuid":"bebcb3de-5615-40f3-a8e4-1ebf454a0cb1"},{"origin":{"id":242210,"publication_date":"2024-01-31"},"id":1237046,"name":"O\u015bwiadczenie","file":{"id":1378859,"name":"zal. 1 Oswiadczenie o braku powiazan FENG.pdf","created_at":"2024-01-31 09:10:21","created_by":{"forename":"Paulina","surname":"Gruszka"},"uri":"/api/files/1378859"},"group_uuid":"f4d0ffa5-3f32-415b-b111-ab194d5a0267"},{"origin":{"id":242210,"publication_date":"2024-01-31"},"id":1237047,"name":"RfQ","file":{"id":1378860,"name":"RfQ_16_2024_G_KONGO.pdf","created_at":"2024-01-31 09:10:28","created_by":{"forename":"Paulina","surname":"Gruszka"},"uri":"/api/files/1378860"},"group_uuid":"dcc61b91-124a-4a2e-92b9-17c48c1d7e62"},{"origin":{"id":242210,"publication_date":"2024-01-31"},"id":1237048,"name":"Att. 1 Statement","file":{"id":1378861,"name":"att. 1 Statement \u2014 FENG.pdf","created_at":"2024-01-31 09:10:42","created_by":{"forename":"Paulina","surname":"Gruszka"},"uri":"/api/files/1378861"},"group_uuid":"918c93d0-5652-4db2-8ecf-0c9b3c1957c6"}]},"dictionaries":{"announcement_status_draft":1,"announcement_status_published":2},"favorite":null,"badge":null,"offer_set_badge_count":null,"question_badge_count":null}}